<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="deo270078" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">DEN Open</journal-id><journal-id journal-id-type="iso-abbrev">DEN Open</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2692-4609</journal-id><journal-id journal-id-type="publisher-id">DEO2</journal-id><journal-title-group><journal-title>DEN Open</journal-title></journal-title-group><issn pub-type="epub">2692-4609</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39959850</article-id><article-id pub-id-type="pmc">PMC11827579</article-id>
<article-id pub-id-type="doi">10.1002/deo2.70078</article-id><article-id pub-id-type="publisher-id">DEO270078</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Factors associated with delayed bleeding following ampullectomy: A retrospective cohort study</article-title><alt-title alt-title-type="left-running-head">PAWLAK <sc>et&#x000a0;al</sc>.</alt-title></title-group><contrib-group><contrib id="deo270078-cr-0001" contrib-type="author"><name><surname>Pawlak</surname><given-names>Katarzyna M.</given-names></name><xref rid="deo270078-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270078-cr-0002" contrib-type="author"><name><surname>Khalaf</surname><given-names>Kareem</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5534-7533</contrib-id><xref rid="deo270078-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270078-cr-0003" contrib-type="author"><name><surname>Gupta</surname><given-names>Sunil</given-names></name><xref rid="deo270078-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270078-cr-0004" contrib-type="author"><name><surname>Tham</surname><given-names>Daniel</given-names></name><xref rid="deo270078-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270078-cr-0005" contrib-type="author"><name><surname>Chon</surname><given-names>Joseph</given-names></name><xref rid="deo270078-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="deo270078-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo270078-cr-0006" contrib-type="author"><name><surname>Mokhtar</surname><given-names>Ahmed H.</given-names></name><xref rid="deo270078-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270078-cr-0007" contrib-type="author"><name><surname>Na</surname><given-names>Caleb</given-names></name><xref rid="deo270078-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270078-cr-0008" contrib-type="author"><name><surname>Mahjoob</surname><given-names>Maryam</given-names></name><xref rid="deo270078-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="deo270078-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo270078-cr-0009" contrib-type="author"><name><surname>Di Fonzo</surname><given-names>David M.P.</given-names></name><xref rid="deo270078-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="deo270078-cr-0010" contrib-type="author"><name><surname>Mosko</surname><given-names>Jeffrey D.</given-names></name><xref rid="deo270078-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270078-cr-0011" contrib-type="author"><name><surname>Teshima</surname><given-names>Christopher W.</given-names></name><xref rid="deo270078-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270078-cr-0012" contrib-type="author"><name><surname>May</surname><given-names>Gary R.</given-names></name><xref rid="deo270078-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270078-cr-0013" contrib-type="author" corresp="yes"><name><surname>Calo</surname><given-names>Natalia Causada</given-names></name><xref rid="deo270078-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>natalia.ccalo@gmail.com</email></address></contrib></contrib-group><aff id="deo270078-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Division of Gastroenterology</named-content>
<institution>St. Michael's Hospital, University of Toronto</institution>
<city>Toronto</city>
<country country="CA">Canada</country>
</aff><aff id="deo270078-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Temerty Faculty of Medicine</named-content>
<institution>University of Toronto</institution>
<city>Toronto</city>
<country country="CA">Canada</country>
</aff><aff id="deo270078-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Internal Medicine</named-content>
<institution>McGill University Health Centre</institution>
<city>Montreal</city>
<country country="CA">Canada</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>Natalia Causada Calo, 16&#x02010;046 Cardinal Carter Wing, 30 Bond Street, Toronto, Ontario, M5B1W8, Canada.<break/> Email: <email>natalia.ccalo@gmail.com</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>14</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2025</year></pub-date><volume>5</volume><issue seq="16">1</issue><issue-id pub-id-type="doi">10.1002/deo2.v5.1</issue-id><elocation-id>e70078</elocation-id><history>
<date date-type="rev-recd"><day>28</day><month>1</month><year>2025</year></date>
<date date-type="received"><day>10</day><month>10</month><year>2024</year></date>
<date date-type="accepted"><day>01</day><month>2</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">DEN Open</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:DEO2-5-e70078.pdf"/><abstract><title>Abstract</title><sec id="deo270078-sec-0010"><title>Introduction and objectives</title><p>Endoscopic ampullectomy is the preferred treatment for selected periampullary lesions, yet up to 10.6% of patients may experience delayed bleeding post&#x02010;procedure. This study aims to identify predictors for bleeding, which remain poorly understood.</p></sec><sec id="deo270078-sec-0020"><title>Methods</title><p>This was a single&#x02010;center retrospective cohort study of adult patients who underwent endoscopic ampullectomy (EA) between January 2011 and September 2023. The primary outcome was the risk factors for delayed bleeding, defined as post&#x02010;procedural bleeding that necessitated either an emergency department visit, hospital admission, blood transfusion, or re&#x02010;intervention. Secondary outcomes included adverse events, such as perforation and pancreatitis.</p></sec><sec id="deo270078-sec-0030"><title>Results</title><p>A total of 113 patients underwent EA, and 25 (22.1%) experienced delayed bleeding. Of these, 20 (80%) required repeat endoscopy, six (24%) needed blood transfusions, and three (12%) were managed conservatively. Multivariable logistic regression analysis identified international normalized ratio&#x000a0;&#x02265;1.2 (odds ratio [OR] 3.32, 95% confidence interval [95% CI] 1.03&#x02013;10.74, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.05), presence of high&#x02010;grade dysplasia or intramucosal cancer (OR 3.76, 95% CI 1.20&#x02013;11.81, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.03), female sex (OR 3.14, 95% CI 1.11&#x02013;8.93, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.03), size of lesion (OR 1.04, 95% CI 1.01&#x02013;1.08, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.03) and procedure duration (OR 0.98, 95% CI 0.97&#x02013;0.99, <italic toggle="yes">p</italic> = 0.04) as independent predictors of delayed bleeding.</p></sec><sec id="deo270078-sec-0040"><title>Conclusion</title><p>Several factors, including features of high&#x02010;grade dysplasia&#x02010;intramucosal cancer, international normalized ratio &#x02265;1.2, female sex, lesion size, and procedure duration are associated with delayed post&#x02010;ampullectomy bleeding. These factors should be taken into consideration when strategizing the reduction of post&#x02010;ampullectomy bleeding.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="deo270078-kwd-0001">ampullary lesions</kwd><kwd id="deo270078-kwd-0002">ampullectomy</kwd><kwd id="deo270078-kwd-0003">bleeding</kwd><kwd id="deo270078-kwd-0004">endoscopic resection</kwd><kwd id="deo270078-kwd-0005">endoscopic retrograde cholangiopancreatography</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>None</funding-source></award-group></funding-group><counts><fig-count count="1"/><table-count count="3"/><page-count count="8"/><word-count count="4627"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:27.02.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="deo270078-sec-0050"><title>INTRODUCTION</title><p>Periampullary lesions represent 10% of all duodenal tumors.<xref rid="deo270078-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> Historically, surgical resection was the primary treatment modality for periampullary lesions.<xref rid="deo270078-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> However, it is associated with a 10% risk of mortality, and up to 65% risk of morbidity,<xref rid="deo270078-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> including pancreatic fistulas, internal hemorrhage, and wound infection.<xref rid="deo270078-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> The detection of periampullary lesions has increased due to more widespread upper gastrointestinal endoscopy and improved optical technology.<xref rid="deo270078-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> Most of these lesions have a benign morphology or are present at an early stage, providing an opportunity for less&#x02010;invasive curative resection approaches.<xref rid="deo270078-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="deo270078-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> Specifically, endoscopic ampullectomy (EA) has become the preferred resection modality in these selected patients.<xref rid="deo270078-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> However, this is not without risk, as complications such as bleeding may occur both intra&#x02010;procedurally or manifest as delayed hemorrhage.<xref rid="deo270078-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="deo270078-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref>
</p><p>The intricacies of the ampullary region, are characterized by a rich vascular network and proximity to major vessels. Hypothetically, the bleeding after the procedure can come from both sources, namely, miniature transected branches of the gastroduodenal artery in this area, but also small capillary veins from the submucosal space, heightening the risk of hemorrhagic events.<xref rid="deo270078-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="deo270078-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> Indeed, the risk of post&#x02010;ampullectomy bleeding has been reported in up to 10.6% of cases in different series. It requires vigilant postoperative monitoring and timely intervention<xref rid="deo270078-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="deo270078-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="deo270078-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>, <xref rid="deo270078-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> As such, the objective of this study was to identify and investigate the predictors for delayed bleeding in the endoscopic treatment of periampullary lesions.</p></sec><sec id="deo270078-sec-0060"><title>METHODS</title><sec id="deo270078-sec-0070"><title>Study design</title><p>This was a retrospective cohort study of adult patients referred to a high&#x02010;volume tertiary care center for the endoscopic resection of a lesion of the major papilla, between January 2011 and December 2023. Cases were identified through a prospectively maintained endoscopic retrograde cholangiopancreatography registry. The registry was approved by the Institutional Research Ethics Board (REB #23&#x02010;142).</p></sec><sec id="deo270078-sec-0080"><title>Study population</title><p>Adult patients&#x000a0;(&#x0003e;&#x000a0;18 years of age) requiring EA for the treatment of ampullary lesions were included. Lesions may have been detected through endoscopy and staged with various imaging modalities, including initial endoscopic assessment, abdominal ultrasound, CT scan, magnetic resonance cholangiopancreatography, and endoscopic ultrasound, particularly to determine intraductal extension which had to be&#x000a0;&#x0003c;&#x000a0;1&#x000a0;cm. Characteristics of lesions that were considered favorable for benign morphology included features such as those confined to the mucosa, a soft consistency, lack of an ulcerative surface or spontaneous bleeding, lack of malignant features in advanced imaging, and lesions with less than 1&#x000a0;cm of intraductal growth.<xref rid="deo270078-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="deo270078-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> All patients included in this study had superficial targeted biopsies taken as part of the evaluation process prior to EA. Among all patients, the biopsies revealed low&#x02010;grade dysplasia (LGD) in 83 patients, high&#x02010;grade dysplasia (HGD) in 28 patients, and Tis in two patients. Treatment for all patients, including those diagnosed as Tis, was proposed based on multidisciplinary consensus, and after patients&#x02019; agreement. No patients underwent EA for diagnostic purposes. Patients with incomplete data records were excluded. Data, including patient demographics, procedural indications, procedural success, and adverse events, were extracted from the registry.</p></sec><sec id="deo270078-sec-0090"><title>Objectives</title><p>The primary objective was to identify independent predictors of delayed post&#x02010;ampullectomy bleeding. The secondary outcomes were time&#x02010;to&#x02010;delayed bleeding, length of hospital stay, and other adverse events, including perforation and pancreatitis.</p></sec><sec id="deo270078-sec-0100"><title>Outcome definition</title><p>Delayed bleeding was defined as all bleeding events occurring after completing the procedure till the first month following EA confirmed endoscopically and requiring additional management including repeat endoscopy in cases of a visible active source of bleeding in the post&#x02010;ampullectomy area or visible transected vessels which could be a potential cause of bleeding in correspondence to clinical manifestation. Also, supportive treatment, transfusion, interventional radiology treatment, repeat hospitalization, or emergency department visits.<xref rid="deo270078-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>
</p></sec><sec id="deo270078-sec-0110"><title>Procedure description</title><p>Procedures were performed by two expert endoscopists with over 15 years of experience in EA under general anesthesia or conscious sedation, depending on the patients&#x02019; procedural tolerance and lesion morphology. A duodenoscope was used for the entire procedure. The endoscopic assessment of the ampulla was performed in all cases to exclude malignant features, namely, deep invasion features based on lesion morphology and vascular and surface patterns. In all cases, the bile duct was cannulated for the assessment of intraductal extension. Where possible, the pancreatic duct was cannulated for evaluation of its anatomy and further guidance for pancreatic duct stent placement. In select cases, a submucosal injection consisting of methylene blue and saline was performed to the inferior aspect of the periampullary lesions, to facilitate visualization and ensure complete resection. Standard, medium&#x02010;stiffness, braided polypectomy snares (typically 15&#x000a0;mm, Olympus SnareMaster Plus), were utilized. A blended electrosurgical current was employed for all lesions (Erbe electrosurgical generators with the setting of Endocut Q, effect 3). When possible, the goal was to obtain an en&#x02010;bloc resection. For laterally spreading lesions, piecemeal resection was usually required. For lesions with&#x000a0;&#x0003c;&#x000a0;1&#x000a0;cm intraductal involvement, biliary sphincterotomy and extraction balloon were used to expose the intraductal component from within the common bile duct. Snare resection was utilized to remove any intraductal growth if present. In cases of intraprocedural bleeding or visible transected vessels at the resection base, the management and prophylaxis of bleeding was made by epinephrine injection, hemostatic clips placement, or coagulation by the tip of the snare or argon plasma coagulation, at the discretion of endoscopists. Most cases had a pancreatic stent placed. Specimens were retrieved with a Roth net (US Endoscopy) and sent for histopathology analysis. After the procedure, all patients were admitted for observation with a similar post&#x02010;procedural management strategy involving overnight fasting, an intravenous infusion of proton pump inhibitor, followed by diet advancement the following day if the patient was well. Antibiotics were not routinely administered. Immediate bleeding was addressed with snare&#x02010;tip soft coagulation or coagulation graspers (Coagrasper; Olympus). An indomethacin suppository was routinely administered post&#x02010;procedure for pancreatitis prophylaxis. In cases of delayed bleeding, the step&#x02010;up treatment strategy was utilized, starting with a repeat endoscopy, followed by interventional radiology and surgical treatment if prior options failed. A blood transfusion was administered depending on the patient's clinical condition and was managed on a case&#x02010;to&#x02010;case basis.</p></sec><sec id="deo270078-sec-0120"><title>Statistical analysis</title><p>Descriptive statistics were reported as mean with standard deviations or percentages with 95% confidence intervals. Categorical variables were compared with chi&#x02010;square. To assess for factors associated with delayed bleeding, variables were divided into three broad categories: patient&#x02010;, lesion&#x02010;, and procedure&#x02010;related. Variables were chosen based on biological plausibility and previous literature and the intent of the logistic regression analysis was to identify predictors of delayed bleeding and was not conceptualized to infer causation of bleeding. The patient&#x02010;related variables were biological sex, age, and use of antithrombotic drugs; lesion&#x02010;related variables included: lesion morphology as per the Paris classification, lesion size, and histology. International normalized ratio (INR) was also included as a parameter of coagulation status. Importantly, most patients had INRs that were close to normality to safely undergo the procedure. The distribution of INR values was binomial in our sample and hence, the cutoff point of 1.2 was chosen to enter it in the logistic regression. Procedure&#x02010;related variables included: procedure duration, intraprocedural bleeding, type of resection (en bloc vs. piecemeal), and prophylaxis of bleeding (use of clips, cautery, injection) in the absence of intraprocedural bleeding. Variables were introduced, one at a time, into a multivariable logistic regression model. Logistic regression estimates were expressed as odds ratio (OR) with 95% confidence intervals. Receiver operating characteristic (ROC) analysis was performed to describe the accuracy of the prediction model (logistic regression). Cox Proportional Hazards Regression was used to examine the time&#x02010;to&#x02010;event data for the main outcome. Additionally, survival analyses were performed to construct Kaplan&#x02010;Meier curves and log&#x02010;rank tests to visualize and compare event&#x02010;time distributions. All statistical tests were two&#x02010;sided and considered significant at <italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.05. Statistical analysis was performed with STATA v. 18.0.</p></sec></sec><sec id="deo270078-sec-0130"><title>RESULTS</title><sec id="deo270078-sec-0140"><title>Baseline characteristics</title><p>This study included 113 consecutive patients (54.9% female, mean age 66.2&#x000a0;&#x000b1;&#x000a0;12.2 years) with confirmed adenomas with dysplasia (LGD&#x000a0;=&#x000a0;83 and HGD&#x000a0;=&#x000a0;28) or carcinoma in situ (two patients), who underwent EA. The mean lesion size was 27.0&#x000a0;&#x000b1;&#x000a0;14.3&#x000a0;mm and most lesions were described as 0&#x02010;Is (96; 85.0%) as per the Paris classification.<xref rid="deo270078-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> The common bile duct was involved in 12 cases (10.6%). Further clinical and lesion characteristics are presented in Tables&#x000a0;<xref rid="deo270078-tbl-0001" ref-type="table">1</xref> and&#x000a0;<xref rid="deo270078-tbl-0002" ref-type="table">2</xref>.</p><table-wrap position="float" id="deo270078-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Patient's characteristics.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="." span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">
<p>All patients</p>
<p>
<italic toggle="yes">n</italic>&#x000a0;= 113</p>
</th><th align="left" rowspan="1" colspan="1">
<p>Patients with delayed bleeding</p>
<p>
<italic toggle="yes">n</italic>&#x000a0;= 25</p>
</th><th align="left" rowspan="1" colspan="1">
<p>Patients without delayed bleeding</p>
<p>
<italic toggle="yes">n</italic>&#x000a0;= 88</p>
</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>Age (years, mean, SD)</bold>
</td><td align="char" char="plusmn" rowspan="1" colspan="1">66.2&#x000a0;&#x000b1; 12.2</td><td align="char" char="plusmn" rowspan="1" colspan="1">65.8&#x000a0;&#x000b1; 13.2</td><td align="char" char="plusmn" rowspan="1" colspan="1">66.4&#x000a0;&#x000b1; 12.0</td><td align="char" rowspan="1" colspan="1">0.82</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Women (<italic toggle="yes">n</italic>, %)</bold>
</td><td align="char" rowspan="1" colspan="1">51 (45.1)</td><td align="char" rowspan="1" colspan="1">15 (60.0)</td><td align="char" rowspan="1" colspan="1">36 (40.9)</td><td align="char" rowspan="1" colspan="1">0.09</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Comorbidities (<italic toggle="yes">n</italic>, %)</bold>
</td><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Hypertension</td><td align="char" rowspan="1" colspan="1">49 (43.3)</td><td align="char" rowspan="1" colspan="1">15 (60.0)</td><td align="char" rowspan="1" colspan="1">34 (38.6)</td><td align="char" rowspan="1" colspan="1">0.06</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Diabetes mellitus</td><td align="char" rowspan="1" colspan="1">19 (16.8)</td><td align="char" rowspan="1" colspan="1">5 (20.0)</td><td align="char" rowspan="1" colspan="1">14 (15.9)</td><td align="char" rowspan="1" colspan="1">0.63</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Dyslipidemia</td><td align="char" rowspan="1" colspan="1">35 (31.0)</td><td align="char" rowspan="1" colspan="1">11 (44.0)</td><td align="char" rowspan="1" colspan="1">24 (27.3)</td><td align="char" rowspan="1" colspan="1">0.11</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Coronary artery disease</td><td align="char" rowspan="1" colspan="1">10 (8.8)</td><td align="char" rowspan="1" colspan="1">3 (12.0)</td><td align="char" rowspan="1" colspan="1">7 (8.0)</td><td align="char" rowspan="1" colspan="1">0.53</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Obesity</td><td align="char" rowspan="1" colspan="1">5 (4.4)</td><td align="char" rowspan="1" colspan="1">1 (4.0)</td><td align="char" rowspan="1" colspan="1">4 (4.5)</td><td align="char" rowspan="1" colspan="1">0.91</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Cirrhosis</td><td align="char" rowspan="1" colspan="1">2 (1.8)</td><td align="char" rowspan="1" colspan="1">1 (4.0)</td><td align="char" rowspan="1" colspan="1">1 (1.1)</td><td align="char" rowspan="1" colspan="1">0.34</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Peripheral arterial disease</td><td align="char" rowspan="1" colspan="1">5 (4.4)</td><td align="char" rowspan="1" colspan="1">1 (4.0)</td><td align="char" rowspan="1" colspan="1">4 (4.5)</td><td align="char" rowspan="1" colspan="1">0.91</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Arrhythmia</td><td align="char" rowspan="1" colspan="1">8 (7.1)</td><td align="char" rowspan="1" colspan="1">1 (4.0)</td><td align="char" rowspan="1" colspan="1">7 (8.0)</td><td align="char" rowspan="1" colspan="1">0.50</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Thrombosis</td><td align="char" rowspan="1" colspan="1">5 (4.4)</td><td align="char" rowspan="1" colspan="1">0 (0)</td><td align="char" rowspan="1" colspan="1">5 (5.7)</td><td align="char" rowspan="1" colspan="1">0.22</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Prior diagnosis of cancer</td><td align="char" rowspan="1" colspan="1">18 (16.1)</td><td align="char" rowspan="1" colspan="1">3 (12.0)</td><td align="char" rowspan="1" colspan="1">15 (17.1)</td><td align="char" rowspan="1" colspan="1">0.54</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Laboratory Tests</bold>
</td><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">INR (median (IQR))</td><td align="char" rowspan="1" colspan="1">1.1 (1.1&#x02013;1.2)</td><td align="char" rowspan="1" colspan="1">1.20 (1.1&#x02013;1.3)</td><td align="char" rowspan="1" colspan="1">1.1 (1.0&#x02013;1.1)</td><td align="char" rowspan="1" colspan="1">0.01</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Platelet Count</td><td align="char" char="plusmn" rowspan="1" colspan="1">213.8&#x000a0;&#x000b1; 64.6</td><td align="char" char="plusmn" rowspan="1" colspan="1">215.3&#x000a0;&#x000b1; 61.3</td><td align="char" char="plusmn" rowspan="1" colspan="1">208.3&#x000a0;&#x000b1; 76.2</td><td align="char" rowspan="1" colspan="1">0.63</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Creatinine</td><td align="char" char="plusmn" rowspan="1" colspan="1">85.3&#x000a0;&#x000b1; 28.9</td><td align="char" char="plusmn" rowspan="1" colspan="1">81.8&#x000a0;&#x000b1; 20.7</td><td align="char" char="plusmn" rowspan="1" colspan="1">86.3&#x000a0;&#x000b1; 30.1</td><td align="char" rowspan="1" colspan="1">0.49</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Hemoglobin</td><td align="char" char="plusmn" rowspan="1" colspan="1">123.1&#x000a0;&#x000b1; 18.0</td><td align="char" char="plusmn" rowspan="1" colspan="1">120.6&#x000a0;&#x000b1; 21.2</td><td align="char" char="plusmn" rowspan="1" colspan="1">123.8&#x000a0;&#x000b1; 17.1</td><td align="char" rowspan="1" colspan="1">0.44</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Bilirubin</td><td align="char" char="plusmn" rowspan="1" colspan="1">14.9&#x000a0;&#x000b1; 8.4</td><td align="char" char="plusmn" rowspan="1" colspan="1">16.9&#x000a0;&#x000b1; 11.9</td><td align="char" char="plusmn" rowspan="1" colspan="1">14.3&#x000a0;&#x000b1; 7.1</td><td align="char" rowspan="1" colspan="1">0.17</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>ASA classification</bold>
</td><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">ASA 1 &#x00026; 2</td><td align="char" rowspan="1" colspan="1">69 (61.10)</td><td align="char" rowspan="1" colspan="1">20 (80.0)</td><td align="char" rowspan="1" colspan="1">49 (55.70)</td><td align="left" rowspan="2" colspan="1">0.03</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">ASA 3 &#x00026; 4</td><td align="char" rowspan="1" colspan="1">44 (38.9)</td><td align="char" rowspan="1" colspan="1">5 (20.0)</td><td align="char" rowspan="1" colspan="1">39 (44.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<p>
<bold>Anti&#x02010;thrombotic medications</bold>
</p>
<p>Anticoagulants antiplatelets</p>
</td><td align="left" rowspan="1" colspan="1">
<p>22 (19.9)</p>
<p>9 (40.9)</p>
<p>13 (59.1)</p>
</td><td align="left" rowspan="1" colspan="1">
<p>6 (24.0)</p>
<p>4 (66.7)</p>
<p>2 (33.3)</p>
</td><td align="left" rowspan="1" colspan="1">
<p>16 (18.2)</p>
<p>11 (68.75)</p>
<p>5 (31.25)</p>
</td><td align="left" rowspan="1" colspan="1">0.52</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><table-wrap position="float" id="deo270078-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Baseline lesion and procedure characteristics.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="." span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Baseline lesion and procedure characteristics</th><th align="left" rowspan="1" colspan="1">Total</th><th align="left" rowspan="1" colspan="1">
<p>Patients with delayed bleeding</p>
<p>(<italic toggle="yes">n</italic>&#x000a0;= 25)</p>
</th><th align="left" rowspan="1" colspan="1">
<p>Patients without delayed bleeding</p>
<p>(<italic toggle="yes">n</italic>&#x000a0;= 88)</p>
</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>Size (mm)</bold> (median (IQR))</td><td align="char" rowspan="1" colspan="1">21.0 (15.0&#x02013;30.0)</td><td align="char" rowspan="1" colspan="1">30.0 (20.0&#x02013;40.0)</td><td align="char" rowspan="1" colspan="1">20.0 (15.0&#x02013;30.0)</td><td align="char" rowspan="1" colspan="1">0.09</td></tr><tr><td colspan="5" align="left" rowspan="1">
<bold>Paris classification</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">IIa</td><td align="char" rowspan="1" colspan="1">17.0 (15.0)</td><td align="char" rowspan="1" colspan="1">4.0 (16.0)</td><td align="char" rowspan="1" colspan="1">13.0 (14.8)</td><td align="left" rowspan="2" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">Is</td><td align="char" rowspan="1" colspan="1">96.0 (85.0)</td><td align="char" rowspan="1" colspan="1">21.0 (84.0)</td><td align="char" rowspan="1" colspan="1">75.0 (85.2)</td></tr><tr><td colspan="5" align="left" rowspan="1">
<bold>Genetic predisposition</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Sporadic</td><td align="char" rowspan="1" colspan="1">105.0 (92.9)</td><td align="char" rowspan="1" colspan="1">24.0 (96.0)</td><td align="char" rowspan="1" colspan="1">81.0 (92.1)</td><td align="left" rowspan="2" colspan="1">0.46</td></tr><tr><td align="left" rowspan="1" colspan="1">FAP</td><td align="char" rowspan="1" colspan="1">8.0 (7.1)</td><td align="char" rowspan="1" colspan="1">1.0 (4.0)</td><td align="char" rowspan="1" colspan="1">7.0 (7.8)</td></tr><tr><td colspan="5" align="left" rowspan="1">
<bold>Resection</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">En&#x02010;bloc</td><td align="char" rowspan="1" colspan="1">56.0 (49.6)</td><td align="char" rowspan="1" colspan="1">10.0 (40.0)</td><td align="char" rowspan="1" colspan="1">46.0 (52.3)</td><td align="left" rowspan="2" colspan="1">0.30</td></tr><tr><td align="left" rowspan="1" colspan="1">Piecemeal</td><td align="char" rowspan="1" colspan="1">57.0 (50.4)</td><td align="char" rowspan="1" colspan="1">15.0 (60.0)</td><td align="char" rowspan="1" colspan="1">42.0 (47.73)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Biliary Sphincterotomy performed</bold>
</td><td align="char" rowspan="1" colspan="1">33.0 (29.2)</td><td align="char" rowspan="1" colspan="1">10.0 (40.0)</td><td align="char" rowspan="1" colspan="1">23.0 (26.1)</td><td align="char" rowspan="1" colspan="1">0.18</td></tr><tr><td colspan="5" align="left" rowspan="1">
<bold>Ductal involvement</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">CBD involvement</td><td align="char" rowspan="1" colspan="1">12.0 (10.6)</td><td align="char" rowspan="1" colspan="1">4.0 (16.0)</td><td align="char" rowspan="1" colspan="1">8.0 (9.1)</td><td align="char" rowspan="1" colspan="1">0.32</td></tr><tr><td align="left" rowspan="1" colspan="1">CBD stent placed</td><td align="char" rowspan="1" colspan="1">71.0 (62.8)</td><td align="char" rowspan="1" colspan="1">15.0 (60.0)</td><td align="char" rowspan="1" colspan="1">56.0 (63.6)</td><td align="char" rowspan="1" colspan="1">0.74</td></tr><tr><td align="left" rowspan="1" colspan="1">PD stent placed</td><td align="char" rowspan="1" colspan="1">98.0 (86.7)</td><td align="char" rowspan="1" colspan="1">23.0 (84.0)</td><td align="char" rowspan="1" colspan="1">77.0 (87.5)</td><td align="char" rowspan="1" colspan="1">0.65</td></tr><tr><td colspan="5" align="left" rowspan="1">
<bold>Pathology</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">HGD/cancer</td><td align="char" rowspan="1" colspan="1">65.0 (57.2)</td><td align="char" rowspan="1" colspan="1">19.0 (76.0)</td><td align="char" rowspan="1" colspan="1">46.0 (52.3)</td><td align="char" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Pancreatitis</bold>
</td><td align="char" rowspan="1" colspan="1">19.0 (16.8)</td><td align="char" rowspan="1" colspan="1">2.0 (8.0)</td><td align="char" rowspan="1" colspan="1">17.0 (19.3)</td><td align="char" rowspan="1" colspan="1">0.18</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Perforation</bold>
</td><td align="char" rowspan="1" colspan="1">7.0 (6.2)</td><td align="char" rowspan="1" colspan="1">2.0 (8.0)</td><td align="char" rowspan="1" colspan="1">5.0 (5.7)</td><td align="char" rowspan="1" colspan="1">0.67</td></tr><tr><td align="left" rowspan="1" colspan="1">
<p>
<bold>Length of hospital stay (days)</bold>
</p>
<p>(median (IQR))</p>
</td><td align="char" rowspan="1" colspan="1">5.0 (4.0&#x02013;6.0)</td><td align="char" rowspan="1" colspan="1">7 (6.0&#x02013;8.0)</td><td align="char" rowspan="1" colspan="1">4.0 (3.0&#x02013;5.3)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Procedure duration (min) (median (IQR))</bold>
</td><td align="char" rowspan="1" colspan="1">60 (42.0&#x02013;70.0)</td><td align="char" rowspan="1" colspan="1">47 (40.0&#x02013;60.0)</td><td align="char" rowspan="1" colspan="1">60 (45.0&#x02013;75.0)</td><td align="char" rowspan="1" colspan="1">0.03</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="deo270078-sec-0150"><title>Endoscopic ampullectomy</title><p>The resection approach as en&#x02010;bloc or piecemeal was determined by the morphology of the lesion, and both methods were comparably performed (49.6% and 50.4%, respectively). Biliary sphincterotomy was performed in 33 (29.2%) cases. CBD involvement was confirmed in 10.6% of patients. Biliary and pancreatic stent placement was performed in 62.8% and 86.7% of cases, respectively. Intraprocedural bleeding occurred in 79.6% of cases and the mean procedure duration was 60 (interquartile range [IQR]: 42&#x02013;70) minutes. Details regarding the procedure are described in Table&#x000a0;<xref rid="deo270078-tbl-0002" ref-type="table">2</xref>.</p></sec><sec id="deo270078-sec-0160"><title>Outcomes</title><p>There were 25 (22.1%) patients delayed bleeding (Table&#x000a0;<xref rid="deo270078-tbl-0002" ref-type="table">2</xref>). Delayed bleeding occurred at a median of 24&#x000a0;h (IQR: 6&#x02013;24) post&#x02010;procedure. Twenty&#x02010;one patients (84%) experienced bleeding within 24&#x000a0;h, while only four (16%) experienced delayed bleeding after 24&#x000a0;h. For the management of bleeding, 20 (80%) patients required repeat endoscopic intervention, six (24%) required blood transfusions and five (20%) were managed conservatively. Patients who experienced delayed bleeding had a longer hospital stay (7.0 [IQR: 6.0&#x02013;8.0] days) than those without (4.0 [IQR: 3.0&#x02013;5.3] days).</p><p>A multivariable logistic regression model revealed that the factors independently associated with delayed bleeding included: INR &#x02265;1.2 (OR 3.32, 95% confidence interval [95% CI] 1.03&#x02013;10.74, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.05); HGD/cancer (OR 3.76, 95%CI 1.20&#x02013;11.81, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.03); female sex (OR 3.14, 95% CI 1.11&#x02013;8.93, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.03), lesion size (OR 1.04, 95% CI 1.01&#x02013;1.08, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.03); procedure duration (OR 0.98, 95% CI 0.97&#x02013;0.99, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.04; Table&#x000a0;<xref rid="deo270078-tbl-0003" ref-type="table">3</xref>). This regression model predicts the risk of delayed bleeding accurately 76.5% of the time as shown in the ROC for the diagnostic performance of the model (Figure <xref rid="deo270078-supinfo-0001" ref-type="">S1</xref>).</p><table-wrap position="float" id="deo270078-tbl-0003" content-type="TABLE"><label>TABLE 3</label><caption><p>Multivariable analysis for post&#x02010;ampullectomy delayed bleeding.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Characteristic</th><th align="left" rowspan="1" colspan="1">Multivariate OR for delayed bleed (95% CI)</th><th align="left" rowspan="1" colspan="1">Standard error</th><th align="left" rowspan="1" colspan="1">95% Confidence interval</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">HGD or cancer</td><td align="left" rowspan="1" colspan="1">3.76</td><td align="left" rowspan="1" colspan="1">2.19</td><td align="left" rowspan="1" colspan="1">1.20&#x02013;11.80</td><td align="left" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">Female sex</td><td align="left" rowspan="1" colspan="1">3.15</td><td align="left" rowspan="1" colspan="1">1.67</td><td align="left" rowspan="1" colspan="1">1.11&#x02013;8.93</td><td align="left" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">INR &#x02265;1.2</td><td align="left" rowspan="1" colspan="1">3.32</td><td align="left" rowspan="1" colspan="1">2.00</td><td align="left" rowspan="1" colspan="1">1.02&#x02013;10.73</td><td align="left" rowspan="1" colspan="1">0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Size of lesion (mm)</td><td align="left" rowspan="1" colspan="1">1.04</td><td align="left" rowspan="1" colspan="1">0.02</td><td align="left" rowspan="1" colspan="1">1.01&#x02013;1.10</td><td align="left" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">Procedure duration (min)</td><td align="left" rowspan="1" colspan="1">0.98</td><td align="left" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1">0.97&#x02013;0.99</td><td align="left" rowspan="1" colspan="1">0.04</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>In addition, a multivariable Cox regression analysis was performed to determine time&#x02010;to&#x02010;event risks and to identify any factors that predict delayed bleeding with respect to time. The sole factor associated with time&#x02010;to&#x02010;bleeding was HGD/cancer (hazard ratio 2.6, 95% CI 1.03&#x02013;6.83). Kaplan Meier curves were constructed (Figure&#x000a0;<xref rid="deo270078-fig-0001" ref-type="fig">1</xref>). Overall, adverse events included perforation (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;7, 6.3%) and pancreatitis (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;19, 16.8%), which in most cases had a mild course. There were no deaths in this cohort at 30 days.</p><fig position="float" fig-type="FIGURE" id="deo270078-fig-0001"><label>FIGURE 1</label><caption><p>Time&#x02010;to&#x02010;delayed bleeding Kaplan&#x02010;Meier curve.</p></caption><graphic xlink:href="DEO2-5-e70078-g001" position="anchor" id="jats-graphic-1"/></fig></sec></sec><sec id="deo270078-sec-0170"><title>DISCUSSION</title><p>Delayed bleeding is a well&#x02010;recognized adverse event after EA. Although in most cases the course is moderate in severity, management requires additional resources and increases hospital length of stay.<xref rid="deo270078-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> In this retrospective cohort study, factors that predicted delayed bleeding included features of HGD or cancer, INR &#x02265;1.2, female sex, size of the lesion, and procedure duration. Furthermore, patients who experienced delayed bleeding had a longer hospital stay and 80% required endoscopic re&#x02010;intervention to control the bleeding.</p><p>While there are numerous studies pertaining to the safety and efficacy of EA, there is a dearth of literature reporting on the risk factors for delayed bleeding. This study revealed that HGD or early cancer as compared with LGD might potentially enhance the occurrence of delayed bleeding. In addition, this was the sole factor that was independently associated with a faster time&#x02010;to&#x02010;bleeding with an adjusted hazard ratio of 2.6 (95% CI 1.03&#x02013;6.83). Meunier al.,<xref rid="deo270078-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> identified a trend toward an increased risk of adverse events in the case of malignant histology. Similarly, Jiang et&#x000a0;al.,<xref rid="deo270078-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> in their study showed that patients with high&#x02010;grade intraepithelial neoplasia (HIN) in removed ampullary lesions, were more likely to have post&#x02010;ampullectomy complications in general (OR 6.52, 95% CI 1.45&#x02013;46.77,&#x000a0;<italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.027). This finding may be related to a hypothetically increased neovascularization in more advanced lesions. However, it is important to note that this association is based on post&#x02010;procedural pathology, which limits its utility for predicting bleeding risk prior to the procedure unless the histology can be confidently determined a priori. Ideally, pre&#x02010;procedural thorough evaluation with digital chromoendoscopy could provide critical insight into the lesion's histology.<xref rid="deo270078-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> Moreover, the endoscopic surface and pit pattern of ampullary adenomas differs from colorectal adenomas and the correlation with the final pathology in the specimen analysis is less reliable. Given that, further efforts are needed to help improve pre&#x02010;procedural ampullary adenoma assessment and histological prediction.</p><p>Another relevant predictor of delayed bleeding was INR &#x02265;1.2. The level of 1.2 as a cut&#x02010;off was equivocal only to the upper normal limit of INR as most patients had their INR corrected prior to resection. Despite this, a slight increase in the INR may be associated with a greater risk of delayed bleeding. In 84% of patients, bleeding occurred within 24&#x000a0;h of EA, highlighting the importance of close monitoring in this early period. The risk of delayed bleeding significantly diminished after 24&#x000a0;h, particularly those with an INR&#x000a0;&#x0003c;1.2, indicating that these patients may be able to be discharged with a hospital length of stay of 1 day. In terms of potential causes for INR &#x02265;1.2, the use of antiplatelet or anticoagulant medications was not associated with delayed bleeding. In our study, only six (24%) patients among whom delayed bleeding occurred, were on pre&#x02010;procedural anticoagulation (two on dual antiplatelet therapy and four on low doses of aspirin of 81&#x000a0;mg). In addition, in all cases medications were held according to local standards, namely, our practice is to withhold anticoagulation medications for 3&#x02013;5 days prior to an EA, depending on the medication.<xref rid="deo270078-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="deo270078-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> Although clinical practice often involves discontinuing anticoagulants when a patient is at increased risk of bleeding, our study found that even within the recommended INR range, slight elevations can still pose problems. Specifically, an INR &#x02265;1.2 was identified as a predictor of delayed bleeding, despite most patients having their INR corrected before the procedure. This suggests that while stopping anticoagulants is crucial, managing INR levels within a safe range remains critical to minimizing bleeding risks. Conversely, Meunier et&#x000a0;al.,<xref rid="deo270078-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> demonstrated that anticoagulation was independently related to delayed bleeding after an EA (OR 4.37, 95% CI 2.86&#x02013;5.95). That discrepancy might be related to the fact that our sample size was relatively small, and medications were stopped prior to the procedure. This discrepancy suggests that elevated INR could be influenced by other factors, such as underlying coagulopathy or procedural trauma, rather than solely by anticoagulant therapy. Nonetheless, the mild elevation in the INR as a predictor of bleeding still points out that coagulation dysregulations (either medically or pharmacologically) are likely important determinants in the risks of bleeding. Therefore, as ampullectomy remains a high&#x02010;risk procedure with a risk of delayed bleeding, following guidelines for peri&#x02010;procedural management of anticoagulation is of utmost importance.<xref rid="deo270078-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>
</p><p>Lesion size (particularly exceeding 20&#x000a0;mm) was another relevant predictor for the occurrence of delayed bleeding. A previous study reported a 7% increase in the odds of bleeding with each additional cm in size of an ampullary adenoma (OR 1.07 95% CI 1.01&#x02013;1.13).<xref rid="deo270078-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> Larger lesions require higher vascular supply, regardless of the underlying histology. The resection of larger lesions might theoretically cause larger submucosal damage and further vessel injury, which might cause delayed bleeding. This is also observed after large colonic polypectomy, as described by Burgess et&#x000a0;al.<xref rid="deo270078-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref>
</p><p>Interestingly, prolonged procedure time was associated with a lower odds of bleeding. This may indicate that bleeding vessels could potentially be treated intraprocedurally in longer resections and prevent delayed bleeding, particularly if the injectate contained epinephrine. The effect of the epinephrine may reduce intraprocedural bleeding temporarily and bleeding may become evident once this effect dissipates; depending on the procedure duration, the bleeding may be missed.</p><p>Finally, our study did not find any significant associations between delayed bleeding and other variables, such as age, or other procedural aspects such as en&#x02010;bloc resection, biliary sphincterotomy, stent placement, intraprocedural bleeding, or performed prevention of bleeding like coagulation or defect clipping. There are other studies that reported these variables as risk factors for delayed bleeding.<xref rid="deo270078-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>, <xref rid="deo270078-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>, <xref rid="deo270078-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref>, <xref rid="deo270078-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref>, <xref rid="deo270078-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>, <xref rid="deo270078-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> Moreover, technical factors such as the type of polypectomy snares and cautery settings were not routinely reported in our study and hence, they could not be analyzed, but could potentially impact bleeding risk. Previous data suggests that alternative techniques, such as using non&#x02010;braided snares and pure&#x02010;cut cautery, could mitigate bleeding risks.<xref rid="deo270078-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref>, <xref rid="deo270078-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref>, <xref rid="deo270078-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> This further suggests that analysis of larger cohorts is important to ascertain patient&#x02010;specific and procedural factors truly influencing the risk of delayed bleeding to establish preventive strategies that optimize post&#x02010;procedural care.<xref rid="deo270078-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref>, <xref rid="deo270078-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref>
</p><p>Our study is not without limitations. First, the observational and retrospective nature of the study introduces inherent biases and confounding by indication, and the potential for incomplete data capture. Second, the single&#x02010;center design may limit generalizability to broader patient populations and centers. However, EA is a high&#x02010;risk procedure that should be performed in expert hands and in tertiary centers. Third, the relatively small sample size might affect the study's power and limit the detection of other predictors. Lastly, the absence of standardized protocols for INR correction may introduce variability in preoperative management. Further studies with larger cohorts are required to validate our findings.</p></sec><sec sec-type="COI-statement" id="deo270078-sec-0180"><title>CONFLICT OF INTEREST STATEMENT</title><p>1. All support for the present manuscript (Funding, provision of study materials, medical writing, article processing charges, etc.) &#x02013; None</p><p>2. Grants or contracts from any entity &#x02013; None</p><p>3. Royalties or licenses &#x02013; None</p><p>4. Consulting fees &#x02013; Boston Scientific (CWT) and Olympus (GRM)</p><p>5. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events &#x02013; Boston Scientific (JDM &#x00026; CWT), Pendopharm (JDM), Vantage (JDM), Medtronic (CWT, JDM &#x00026; GRM), Pentax (GRM) and Fuji (GRM)</p><p>6. Payment for expert testimony &#x02013; None</p><p>7. Support for attending meetings and or travel &#x02013; None</p><p>8. Patents planned, issued, or pending &#x02013; None</p><p>9. Participation on the Data Safety Monitoring Board or Advisory Board &#x02013; Pendopharm, Janssen, Pentax, Fuji, and Boston Scientific (JDM)</p><p>10. Leadership or fiduciary role in another board, society, committee, or advocacy group paid or unpaid &#x02013; None</p><p>11. Stock or stock options &#x02013; None</p><p>12. Receipt of equipment, materials, drugs, medical writing, gifts or other services &#x02013; None</p><p>13. Other financial or non&#x02010;financial interests &#x02013; None</p></sec><sec id="deo270078-sec-0190"><title>ETHICS STATEMENT</title><p>&#x02010;Approval of the research protocol by an Institutional Reviewer Board: Yes, (REB #23&#x02010;142).</p></sec><sec id="deo270078-sec-0200"><title>PATIENT CONSENT STATEMENT</title><p>N/A.</p></sec><sec id="deo270078-sec-0210"><title>CLINICAL TRIAL REGISTRATION</title><p>N/A.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="deo270078-supinfo-0001" position="float" content-type="local-data"/><supplementary-material id="deo270078-supitem-0001" position="float" content-type="local-data"><caption><p>
<bold>Figure S1</bold> Receiver operating characteristic (ROC) model.</p></caption><media xlink:href="DEO2-5-e70078-s001.tif"/></supplementary-material></sec></body><back><ref-list id="deo270078-bibl-0001"><title>REFERENCES</title><ref id="deo270078-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="deo270078-cite-0001">
<string-name>
<surname>Kim</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>YI</given-names>
</string-name>. <article-title>Safety of duodenal ampullectomy for benign periampullary tumors</article-title>. <source>Ann Hepatobiliary Pancreat Surg</source>
<year>2017</year>; <volume>21</volume>: <fpage>146</fpage>&#x02013;<lpage>150</lpage>.<pub-id pub-id-type="pmid">28990001</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="deo270078-cite-0002">
<string-name>
<surname>Martin</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Haber</surname>
<given-names>GB</given-names>
</string-name>. <article-title>Ampullary adenoma: Clinical manifestations, diagnosis, and treatment</article-title>. <source>Gastrointest Endosc Clin N Am</source>
<year>2003</year>; <volume>13</volume>: <fpage>649</fpage>&#x02013;<lpage>669</lpage>.<pub-id pub-id-type="pmid">14986792</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="deo270078-cite-0003">
<string-name>
<surname>Grace</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Pitt</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Tompkins</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>DenBesten</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Longmire</surname>
<given-names>WPJ</given-names>
</string-name>. <article-title>Decreased morbidity and mortality after pancreatoduodenectomy</article-title>. <source>Am J Surg</source>
<year>1986</year>; <volume>151</volume>: <fpage>141</fpage>&#x02013;<lpage>149</lpage>.<pub-id pub-id-type="pmid">3946745</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="deo270078-cite-0004">
<string-name>
<surname>Kim</surname>
<given-names>GE</given-names>
</string-name>, <string-name>
<surname>Siddiqui</surname>
<given-names>UD</given-names>
</string-name>. <article-title>Endoscopic Resection Techniques for Duodenal and Ampullary Adenomas</article-title>. <source>VideoGIE</source>
<year>2023</year>; <volume>8</volume>: <fpage>330</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">37575136</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="deo270078-cite-0005">
<string-name>
<surname>Norton</surname>
<given-names>ID</given-names>
</string-name>, <string-name>
<surname>Geller</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Petersen</surname>
<given-names>BT</given-names>
</string-name>, <string-name>
<surname>Sorbi</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Gostout</surname>
<given-names>CJ</given-names>
</string-name>. <article-title>Endoscopic surveillance and ablative therapy for periampullary adenomas</article-title>. <source>Am J Gastroenterol</source>
<year>2001</year>; <volume>96</volume>: <fpage>101</fpage>&#x02013;<lpage>106</lpage>.<pub-id pub-id-type="pmid">11197237</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="deo270078-cite-0006">
<string-name>
<surname>Pittayanon</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Imraporn</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Rerknimitr</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kullavanijaya</surname>
<given-names>P</given-names>
</string-name>. <article-title>Advances in diagnostic endoscopy for duodenal, including ampullary, adenoma</article-title>. <source>Dig Endosc</source>
<year>2014</year>; <volume>26</volume> (Suppl <issue>2</issue>): <fpage>10</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="pmid">24750142</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="deo270078-cite-0007">
<string-name>
<surname>Poley</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Campos</surname>
<given-names>S</given-names>
</string-name>. <article-title>Methods and outcome of the endoscopic treatment of ampullary tumors</article-title>. <source>Ther Adv Gastrointest Endosc</source>
<year>2020</year>; <volume>13</volume>: <elocation-id>2631774519899786</elocation-id>.<pub-id pub-id-type="pmid">32030370</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="deo270078-cite-0008">
<string-name>
<surname>van der Wiel</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Poley</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Koch</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Bruno</surname>
<given-names>MJ</given-names>
</string-name>. <article-title>Endoscopic resection of advanced ampullary adenomas: A single&#x02010;center 14&#x02010;year retrospective cohort study</article-title>. <source>Surg Endosc</source>
<year>2019</year>; <volume>33</volume>: <fpage>1180</fpage>&#x02013;<lpage>1188</lpage>.<pub-id pub-id-type="pmid">30167949</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="deo270078-cite-0009">
<string-name>
<surname>Wang</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Outcome of a novel modified endoscopic papillectomy for duodenal major papilla adenoma</article-title>. <source>Surg Endosc</source>
<year>2020</year>; <volume>34</volume>: <fpage>5160</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">32666256</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="deo270078-cite-0010">
<string-name>
<surname>Bahl</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Vadlamudi</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Yedla</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Smalligan</surname>
<given-names>RD</given-names>
</string-name>. <article-title>&#x02018;Bleeding Dilemma&#x02019;: The Story of a Periampullary Mass</article-title>. <source>Cureus</source>
<year>2018</year>; <volume>10</volume>: <elocation-id>e3035</elocation-id>.<pub-id pub-id-type="pmid">30254824</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="deo270078-cite-0011">
<string-name>
<surname>Spadaccini</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Fugazza</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Frazzoni</surname>
<given-names>L</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Endoscopic papillectomy for neoplastic ampullary lesions: A systematic review with pooled analysis</article-title>. <source>United European Gastroenterol J</source>
<year>2020</year>; <volume>8</volume>: <fpage>44</fpage>&#x02013;<lpage>51</lpage>.</mixed-citation></ref><ref id="deo270078-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="deo270078-cite-0012">
<string-name>
<surname>Alali</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Espino</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Moris</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Endoscopic Resection of Ampullary Tumours: Long&#x02010;term Outcomes and Adverse Events</article-title>. <source>J Can Assoc Gastroenterol</source>
<year>2020</year>; <volume>3</volume>: <fpage>17</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">32010876</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="deo270078-cite-0013">
<string-name>
<surname>Shim</surname>
<given-names>CN</given-names>
</string-name>, <string-name>
<surname>Chung</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Bang</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Clinicopathologic characteristics associated with complications and long&#x02010;term outcomes of endoscopic papillectomy for adenoma</article-title>. <source>Yonsei Med J</source>
<year>2014</year>; <volume>55</volume>: <fpage>644</fpage>&#x02013;<lpage>650</lpage>.<pub-id pub-id-type="pmid">24719130</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="deo270078-cite-0014">
<string-name>
<surname>De Palma</surname>
<given-names>GD</given-names>
</string-name>. <article-title>Endoscopic papillectomy: Indications, techniques, and results</article-title>. <source>World J Gastroenterol</source>
<year>2014</year>; <volume>20</volume>: <fpage>1537</fpage>&#x02013;<lpage>1543</lpage>.<pub-id pub-id-type="pmid">24587629</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="deo270078-cite-0015">
<string-name>
<surname>Bassan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bourke</surname>
<given-names>M</given-names>
</string-name>. <article-title>Endoscopic ampullectomy: A practical guide</article-title>. <source>J Interv Gastroenterol</source>
<year>2012</year>; <volume>2</volume>: <fpage>23</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">22586547</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="deo270078-cite-0016">
<string-name>
<surname>Dumonceau</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Kapral</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Aabakken</surname>
<given-names>L</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>ERCP&#x02010;related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline</article-title>. <source>Endoscopy</source>
<year>2020</year>; <volume>52</volume>: <fpage>127</fpage>&#x02013;<lpage>149</lpage>.<pub-id pub-id-type="pmid">31863440</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="deo270078-cite-0017">
<article-title>The Paris endoscopic classification of superficial neoplastic lesions: Esophagus, stomach, and colon: November 30 to December 1, 2002</article-title>. <source>Gastrointest Endosc</source>
<year>2003</year>; <volume>58</volume> (<issue>6</issue> Suppl): <fpage>S3</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="pmid">14652541</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="deo270078-cite-0018">
<string-name>
<surname>Meunier</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lisotti</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gupta</surname>
<given-names>V</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Oral anticoagulants but not antiplatelet agents increase the risk of delayed bleeding after endoscopic papillectomy: A large study in a tertiary referral center</article-title>. <source>Surg Endosc</source>
<year>2022</year>; <volume>36</volume>: <fpage>7376</fpage>&#x02013;<lpage>7384</lpage>.<pub-id pub-id-type="pmid">35233659</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="deo270078-cite-0019">
<string-name>
<surname>Jiang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Chai</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Linghu</surname>
<given-names>E</given-names>
</string-name>. <article-title>Therapeutic Outcomes and Risk Factors for Complications of Endoscopic Papillectomy: A Retrospective Analysis of a Single&#x02010;Center Study</article-title>. <source>Ther Clin Risk Manag</source>
<year>2021</year>; <volume>17</volume>: <fpage>531</fpage>&#x02013;<lpage>541</lpage>.<pub-id pub-id-type="pmid">34093018</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="deo270078-cite-0020">
<string-name>
<surname>Bateman</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>P</given-names>
</string-name>. <article-title>Lower gastrointestinal endoscopy: Guidance on indications for biopsy</article-title>. <source>Frontline Gastroenterol</source>
<year>2014</year>; <volume>5</volume>: <fpage>96</fpage>&#x02013;<lpage>102</lpage>.<pub-id pub-id-type="pmid">28840915</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="deo270078-cite-0021">
<string-name>
<surname>Abraham</surname>
<given-names>NS</given-names>
</string-name>, <string-name>
<surname>Barkun</surname>
<given-names>AN</given-names>
</string-name>, <string-name>
<surname>Sauer</surname>
<given-names>BG</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>American College of Gastroenterology&#x02010;Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period</article-title>. <source>J Can Assoc Gastroenterol</source>
<year>2022</year>; <volume>5</volume>: <fpage>100</fpage>&#x02013;<lpage>101</lpage>.<pub-id pub-id-type="pmid">35368325</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="deo270078-cite-0022">
<string-name>
<surname>Acosta</surname>
<given-names>RD</given-names>
</string-name>, <string-name>
<surname>Abraham</surname>
<given-names>NS</given-names>
</string-name>, <string-name>
<surname>Chandrasekhara</surname>
<given-names>V</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>The management of antithrombotic agents for patients undergoing GI endoscopy</article-title>. <source>Gastrointestinal Endoscopy</source>
<year>2016</year>; <volume>83</volume>: <fpage>3</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">26621548</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="deo270078-cite-0023">
<string-name>
<surname>Veitch</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Vanbiervliet</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Gershlick</surname>
<given-names>AH</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines</article-title>. <source>Gut</source>
<year>2016</year>; <volume>65</volume>: <fpage>374</fpage>&#x02013;<lpage>389</lpage>.<pub-id pub-id-type="pmid">26873868</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="deo270078-cite-0024">
<string-name>
<surname>Burgess</surname>
<given-names>NG</given-names>
</string-name>, <string-name>
<surname>Metz</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Williams</surname>
<given-names>SJ</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Risk factors for intraprocedural and clinically significant delayed bleeding after wide&#x02010;field endoscopic mucosal resection of large colonic lesions</article-title>. <source>Clin Gastroenterol Hepatol</source>
<year>2014</year>; <volume>12</volume>: <fpage>651</fpage>&#x02013;<lpage>661</lpage>.e1&#x02013;3.<pub-id pub-id-type="pmid">24090728</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="deo270078-cite-0025">
<string-name>
<surname>Chirkov</surname>
<given-names>YY</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>
<given-names>TH</given-names>
</string-name>, <string-name>
<surname>Horowitz</surname>
<given-names>JD</given-names>
</string-name>. <article-title>Impairment of anti&#x02010;aggregatory responses to nitric oxide and prostacyclin: Mechanisms and clinical implications in cardiovascular disease</article-title>. <source>Int J Mol Sci</source>
<year>2022</year>; <volume>23</volume>: <fpage>1042</fpage>.<pub-id pub-id-type="pmid">35162966</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="deo270078-cite-0026">
<string-name>
<surname>Kiattiweerasak</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bongkotvirawan</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Aumpan</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Yamaoka</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Miftahussurur</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Vilaichone</surname>
<given-names>RK</given-names>
</string-name>. <article-title>Predictive factors and prognosis of upper gastrointestinal bleeding in gastric cancer: A large population&#x02010;based study (UGIB&#x02010;GC trial)</article-title>. <source>PLoS One</source>
<year>2023</year>; <volume>18</volume>: <elocation-id>e0291926</elocation-id>.<pub-id pub-id-type="pmid">37729185</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="deo270078-cite-0027">
<string-name>
<surname>Chung</surname>
<given-names>KH</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>JH</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Effect of submucosal injection in endoscopic papillectomy of ampullary tumor: Propensity&#x02010;score matching analysis</article-title>. <source>United European Gastroenterol J</source>
<year>2018</year>; <volume>6</volume>: <fpage>576</fpage>&#x02013;<lpage>585</lpage>.</mixed-citation></ref><ref id="deo270078-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="deo270078-cite-0028">
<string-name>
<surname>Hyun</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>TH</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>JS</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>A prospective multicenter study of submucosal injection to improve endoscopic snare papillectomy for ampullary adenoma</article-title>. <source>Gastrointest Endosc</source>
<year>2017</year>; <volume>85</volume>: <fpage>746</fpage>&#x02013;<lpage>755</lpage>.<pub-id pub-id-type="pmid">27566056</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="deo270078-cite-0029">
<string-name>
<surname>El Hajj</surname>
<given-names>II</given-names>
</string-name>, <string-name>
<surname>Cot&#x000e9;</surname>
<given-names>GA</given-names>
</string-name>. <article-title>Endoscopic diagnosis and management of ampullary lesions</article-title>. <source>Gastrointest Endosc Clin N Am</source>
<year>2013</year>; <volume>23</volume>: <fpage>95</fpage>&#x02013;<lpage>109</lpage>.<pub-id pub-id-type="pmid">23168121</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="deo270078-cite-0030">
<string-name>
<surname>Espinel</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Pinedo</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ojeda</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Del Rio</surname>
<given-names>MG</given-names>
</string-name>. <article-title>Endoscopic management of adenomatous ampullary lesions</article-title>. <source>World J Methodol</source>
<year>2015</year>; <volume>5</volume>: <fpage>127</fpage>&#x02013;<lpage>135</lpage>.<pub-id pub-id-type="pmid">26413485</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="deo270078-cite-0031">
<string-name>
<surname>Hedjoudje</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Cheurfa</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Farha</surname>
<given-names>J</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Safety of different electrocautery modes for endoscopic sphincterotomy: A Bayesian network meta&#x02010;analysis</article-title>. <source>Ther Adv Gastrointest Endosc</source>
<year>2021</year>; <volume>14</volume>: <elocation-id>26317745211062983</elocation-id>.<pub-id pub-id-type="pmid">34993472</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="deo270078-cite-0032">
<string-name>
<surname>Nam</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>RE</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Usefulness of argon plasma coagulation ablation subsequent to endoscopic snare papillectomy for ampullary adenoma</article-title>. <source>Dig Endosc</source>
<year>2018</year>; <volume>30</volume>: <fpage>485</fpage>&#x02013;<lpage>492</lpage>.<pub-id pub-id-type="pmid">29288506</pub-id>
</mixed-citation></ref><ref id="deo270078-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="deo270078-cite-0033">
<string-name>
<surname>Park</surname>
<given-names>SW</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>JS</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Effect of prophylactic endoscopic clipping for prevention of delayed bleeding after endoscopic papillectomy for ampullary neoplasm: A multicenter randomized trial</article-title>. <source>Endoscopy</source>
<year>2022</year>; <volume>54</volume>: <fpage>787</fpage>&#x02013;<lpage>794</lpage>.<pub-id pub-id-type="pmid">35148541</pub-id>
</mixed-citation></ref></ref-list></back></article>